Trials have begun on what researchers say could be a stopgap vaccination against the new coronavirus, testing a century-old tuberculosis vaccine on thousands of people including police in India, health-care workers in Texas and elderly people in the Netherlands. The trials intend to determine whether the vaccine known as BCG, which is used in most of the world outside the U.S. and Western Europe, offers protection against Covid-19, the disease caused by the new coronavirus.

Source: Wall Street Journal May 13, 2020 09:33 UTC